The chief minister accused the Governor of interfering in the state government's affairs and, replying to Purohit's letter made public Monday, indirectly questioned his credentials for the post.
In August, the ED had raided the residential premises of former Ranbaxy CEO Malvinder Mohan Singh and his brother Shivinder Singh in connection with a money laundering case.
Punjab Chief Minister Bhagwant Mann, 48, will tie the nuptial knot in Chandigarh on Thursday, party leaders confirmed.
The Japanese company alleges the earlier Ranbaxy promoters withheld crucial information when they sold the company in 2008.
A few people held a protest against the Punjab Police in Mansa for allegedly stopping them from entering the Moosa village by deploying heavy security ahead of Mann's visit.
The incident is being seen as a major intelligence failure as the office houses the state counter intelligence wing, special task force and some other units.
A controversy erupted after a video of Kiran Bedi purportedly cracking a joke on Sikhs at the launch of her book was widely shared on social media.
'Nothing in this world is permanent. So also in business.' 'And more so in family businesses where family issues often influence business decisions,' point out S Subramanian and Nupur Pavan Bang.
CJI Lalit concurred with the minority view of Justice S Ravindra Bhat who held the EWS quota as "unconstitutional" for excluding poor among SCs, STs and OBCs.
The main accused Barjinder Singh Parwana was among the six more people arrested in connection with the clashes in Patiala that had left four people injured, the Punjab Police said on Sunday.
The company said this was 'important' to reinforce the 'complete disassociation' from its erstwhile promoters -- Malvinder and Shivinder Singh.
Whistle-blowers allege the brothers violated court orders by selling assets like art and real estate worth crores bought by funds from their companies.
The high court imposed various bail conditions on him, including that he shall not tamper with the evidence or influence witnesses, directly or indirectly.
The previous board of Fortis Healthcare had links with Singh brothers and there was an investigation by law firm Luthra and Luthra into Rs 472 crore that was diverted into other companies.
On Wednesday, Daiichi Sankyo's lawyers argued for a stay on stake sale by Fortis, which was opposed by counsels of the hospital chain and promoter entities.
From Ranbaxy to Religare, Aashish Aryan takes you through a maze of legal cases involving Malvinder Mohan Singh and his younger brother Shivinder Mohan Singh. Both are in police custody following a complaint of fund siphoning.
The police have put up barricades, tippers and rolled out water cannons to prevent protesting farmers from entering Chandigarh.
She praised the chief minister for leading the party to "many victories" and taking Punjab on a "road to progress".
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
Fortis Healthcare Executive Vice-Chairman Shivinder Mohan Singh is stepping down from his position to join a philosophical and spiritual organisation.
Financial services group Religare Enteprises Ltd on Tuesday announced a top level management rejig with promoters - incumbent Chairman Malvinder Mohan Singh and his younger brother Shivinder Mohan Singh - stepping down as members of the board.
NCLT allows Shivinder to withdraw petition against his brother Malvinder. Final decision to be taken by family members in their presence.
A cross-border takeover thriller that not only saw corporate action but also diplomatic dealings and slugfests among bankers.
The Enforcement Directorate (ED) on Thursday arrested former Fortis Healthcare promoter Shivinder Mohan Singh in a money laundering case related to the alleged misappropriation of funds at Religare Finvest. A team of ED officials went to Tihar Jail and placed Singh under arrest as per the provisions of the Prevention of Money Laundering Act.
'Had the Congress made Sidhu its CM face, they would have won 80 out of 117 seats.'
When you are the leader, you have to set the pace for the industry
The four ministers -- Tript Rajinder Singh Bajwa, Sukhbinder Singh Sarkaria, Sukhjinder Singh Randhawa and Charanjit Singh Channi -- and around two dozen legislators met in Chandigarh at the residence of Bajwa on Tuesday.
An out-of-court settlement of the feud over Ranbaxy founder Bhai Mohan Singh's will is seemingly imminent between Analjit Singh and Malvinder, Shivender duo, the present promoters of Ranbaxy and Fortis respectively.
Malvinder Singh, President (Pharmaceuticals) and Executive Director, Ranbaxy, says the company aims to touch $5 billion in revenues by 2012, with growth coming from American and European markets.
Daiichi alleged that Singh brothers had concealed and misrepresented critical information concerning US Food and Drug Administration and Department of Justice investigations into Ranbaxy
Fortis Healthcare has also come under the lens of Sebi, which launched an investigation into alleged regulatory lapses
Singh, who was instrumental in building required capabilities in the organisation said his role at Fortis did not allow him to spend time with his family, as the reason behind his resignation.
Markets regulator remains silent but could probe possible violations of takeover code or under fraudulent trade practices, say lawyers.
Not far back, in 2010, SRL Diagnostics, promoted by former Ranbaxy promoters Malvinder and Shivinder Singh, acquired the diagnostic services business of Piramal Healthcare for Rs 600 crore (Rs 6 billion).
Gurgaon hospital to screen cinemas as non-commercial venture.
The Rs 1,550-cr deal expected to be completed by March.
'... And I don't think it really is that despite a lot going wrong.' 'Naiveté or stupidity or trusting the wrong person, the outcome is the same, which is that the group has gone to trash.' 'I'm not OK with people saying I had a role to play in crooking the system, which is not what I did.'
It has exited most non-profitable geographies and is no longer chasing acquisitions. Will the new strategy pay off?
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances